Pharmacy Access Partnership

Jane Boggess, PhD - May 12, 2022


On April 25, 2022 Alaska became the third state to permit pharmacists to provide EC under collaborative protocol with a prescriber.


As with both California and Washington, pharmacist scope of practice in Alaska pertaining to EC has its own characteristics. Below is a summary of Alaska's new regulations pertaining to EC, with text in italics providing a comparison with California and Washington states.


        Collaborative protocols may be with either a MD or Nurse practitioner.


Comment: Similar to Washington, but different from California where only MD's may enter into a collaborative protocol with a pharmacist.


        Protocols must first be approved by the State Board of Pharmacy.


Comment: Similar to WA, but not CA where Board approval is not required.


        Protocols are limited to two years, and then must be resubmitted to the State Board for renewal.


Comment: Same as WA, but not CA where protocols have no specified time limit.


        Regulations require pharmacists to have training on EC - Alaska's recommended pharmacy training program is the online EC program at


Comment: Similar training requirements exist for CA and WA, although both states, possibly because of their less rural nature, favor live programs.


        Regulations require a plan for providing authorizing practitioner with EC patient information, and stipulate a quarterly review process.


Comment: Similar to WA, which requires aggregate information to be sent quarterly to prescriber, but not CA where law is very general on issue of review and documentation.


        Protocols may apply to whole community including individuals with no established relationship with a provider, although prescriber can establish limits.


Comment: Theoretically, the same is true for both CA and WA, although to my knowledge, neither state has implemented restrictions on EC protocols.